Fact CheckerSign in

NCT05297279Recruiting

OMEGA - Dietary Intervention - COPD Trial

Source: ClinicalTrials.gov · Last updated 16 Mar 2026

Brief summary (registry, in English)

A randomized controlled trial of a food delivery dietary intervention targeting increased omega-3 intake to determine whether dietary modifications can improve Chronic Obstructive Pulmonary Disease (COPD) outcomes and attenuate the adverse effects of particulate matter on respiratory health. Investigators believe that study results will comprehensively address the impact of an evidence-based nutrition intervention on COPD health and provide a framework for dietary intervention within other chronic diseases disproportionately impacting susceptible, low-income populations.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
200 (estimated)
First submitted
16 Mar 2022
Start date
1 Mar 2022
Primary completion date
Mar 2027
Lead sponsor
Johns Hopkins University
Diseases
COPD
NCT number
NCT05297279

What you commit to

  • Study type: Interventional
  • Planned participants: 200
  • From 1 Mar 2022 to the primary completion date, Mar 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Other chronic lung disease, except those with history of asthma if it felt by the investigator not to be a primary diagnosis.

Other

  • Participant planning to change residence during study period,
  • Pregnancy or breastfeeding and
  • Reported unwillingness to eat seafood.

Who the study is looking for

  • Age ≥ 40 years,
  • Physician diagnosis of COPD,
  • Global Initiative for Obstructive Lung Disease (GOLD) Stage II-IV disease with Forced Expiratory Volume in the First Second (FEV1)/ Forced Vital Capacity (FVC) \<70% and FEV1 (% predicted) \<80%. IF FEV1/FVC \<70% and FEV1 (% predicted) ≥ 80%, additional requirement will be asked: CAT score ≥ 10. Also, IF available for screening purposes: participant can provide a previous pulmonary function testing (PFT) report within the last 6 months.
  • Tobacco exposure ≥ 10 pack-years,
  • Poverty criteria as determined by residing in a neighborhood with ≥10% of residents living in poverty, consistent with the definition of poverty area OR not access to private health insurance, OR only completed high school education or less.
  • Low omega-3 intake (reported daily intake of EPA+DHA intake \<500 mg via diet and/or supplement) at the screening visit, and
  • Willing to comply with dietary recommendations

Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Johns Hopkins Bayview Campus
Coordinator of this site? Confirm its status
BaltimoreUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.